TMR 245 : Dr. Mobeen Syed : Food Supplements & COVID-19
13 giu 2020 ·
54 min. 45 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
We welcome to the programme Dr. Mobeen Syed, MD, MS—CEO and founder of Drbeen : Personalized Medical Education, and host of the excellent Drbeen Medical Lectures YouTube channel—for an interview...
mostra di più
We welcome to the programme Dr. Mobeen Syed, MD, MS—CEO and founder of Drbeen : Personalized Medical Education, and host of the excellent Drbeen Medical Lectures YouTube channel—for an interview on dietary supplements that he believes may prove helpful in the body's resistance to, and/or fight against, COVID-19.
We discuss: Vitamin C, Vitamin D3, Zinc, Quercetin, and N-acetylcisteine (NAC).
Dr. Mobeen also shares with us his experience of prescribing hydroxychloroquine (in conjunction with other substances) for COVID-19, and gives his reaction to "Lancetgate" (the events surrounding the recent deeply-flawed HCQ/CQ study published by The Lancet).
(NB: Nothing said in this podcast should be understood as medical advice. Please consult your doctor before making any changes to your diet by way of food supplements.)
For show notes please visit https://themindrenewed.com
mostra meno
We discuss: Vitamin C, Vitamin D3, Zinc, Quercetin, and N-acetylcisteine (NAC).
Dr. Mobeen also shares with us his experience of prescribing hydroxychloroquine (in conjunction with other substances) for COVID-19, and gives his reaction to "Lancetgate" (the events surrounding the recent deeply-flawed HCQ/CQ study published by The Lancet).
(NB: Nothing said in this podcast should be understood as medical advice. Please consult your doctor before making any changes to your diet by way of food supplements.)
For show notes please visit https://themindrenewed.com
Informazioni
| Autore | Fringe Radio Network |
| Organizzazione | Fringe Radio Network |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Commenti